未登录

K

Kathleen A. Maguire-Zeiss

georgetown university

H指数:27

被引数:3,847

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Age-related inflammatory changes and perineuronal net dynamics: implications for aging

年龄相关的炎症变化和神经周网动力学：对衰老的启示

Journal of Neuroinflammation

IF10.1

2025-11-190

OAAI

Jedi-1/MEGF12-mediated phagocytosis controls the pro-neurogenic properties of microglia in the ventricular-subventricular zone

IF6.9

2023-11-011

OAAI

Lentiviral Vectors Expressing Chimeric NEDD4 Ubiquitin Ligases: An Innovative Approach for Interfering with Alpha-Synuclein Accumulation

IF5.2

2021-11-214

OAAI

Polychlorinated biphenyls induce oxidative stress and metabolic responses in astrocytes

NEUROTOXICOLOGY

IF3.9

2021-09-0128

OAAI

Environmental toxicants in the brain: A review of astrocytic metabolic dysfunction

ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY

IF4.2

2021-05-0113

OAAI

MMP13 Expression Is Increased Following Mutant α-Synuclein Exposure and Promotes Inflammatory Responses in Microglia

FRONTIERS IN NEUROSCIENCE

IF3.2

2020-12-0211

OAAI

HIV-1 Tat promotes astrocytic release of CCL2 through MMP/PAR-1 signaling

IF5.1

2019-05-2331

OAAI

Matrix metalloproteinase activity stimulates N-cadherin shedding and the soluble Ncadherin ectodomain promotes classical microglial activation

JOURNAL OF NEUROINFLAMMATION

IF10.1

2017-03-1725

OAAI

Protease induced plasticity: matrix metalloproteinase-1 promotes neurostructural changes through activation of protease activated receptor 1

SCIENTIFIC REPORTS

IF3.9

2016-10-2047

OAAI

Activation of MyD88-dependent TLR1/2 signaling by misfolded α-synuclein, a protein linked to neurodegenerative disorders

SCIENCE SIGNALING

IF6.6

2015-05-12250

OAAI

The beneficial effect of a prolyl oligopeptidase inhibitor, KYP-2047, on alpha-synuclein clearance and autophagy in A30P transgenic mouse

NEUROBIOLOGY OF DISEASE

IF5.6

2014-08-0183

OAAI

From student to steward: the Interdisciplinary Program in Neuroscience at Georgetown University as a case study in professional development during doctoral training

MEDICAL EDUCATION ONLINE

IF3.8

2014-07-0711

OAAI

Development of Inducible Leucine-rich Repeat Kinase 2 (LRRK2) Cell Lines for Therapeutics Development in Parkinson's Disease

NEUROTHERAPEUTICS

IF6.9

2013-10-015

OAAI

Microglial Activation and Antioxidant Responses Induced by the Parkinson's Disease Protein α-Synuclein

JOURNAL OF NEUROIMMUNE PHARMACOLOGY

IF3.5

2012-10-10154

OA

α-Synuclein alters toll-like receptor expression

FRONTIERS IN NEUROSCIENCE

IF3.2

2011-01-01161

OAAI

Parkinson-related parkin reduces α-Synuclein phosphorylation in a gene transfer model

MOLECULAR NEURODEGENERATION

IF17.5

2010-11-0475

OAAI

Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease

NATURE MEDICINE

IF50

2010-08-22338

OAAI

Future directions for immune modulation in neurodegenerative disorders: focus on Parkinson's disease

JOURNAL OF NEURAL TRANSMISSION

IF4

2010-06-1234

PREAI

Gene Therapy in Parkinson's Disease Rationale and Current Status

IF7.4

2010-03-0169

OAAI

Alpha-synuclein-directed alterations in membrane electrophysiological properties: potential role for alpha-synuclein pores in cell death

PARKINSONISM & RELATED DISORDERS

IF3.4

2009-12-010

PREAI